CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction

Despite its established inter-individual variability, sildenafil has been the subject of only a few pharmacogenetic investigations, with limited data regarding the genetic modulators of its pharmacokinetics. We conducted a pharmacogenetic substudy of patients randomized to sildenafil (n = 85) in the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pharmacogenomics J
Egile Nagusiak: de Denus, Simon, Rouleau, Jean L., Mann, Douglas L., Huggins, Gordon S., Pereira, Naveen L., Shah, Svati H., Cappola, Thomas P., Fouodjio, René, Mongrain, Ian, Dubé, Marie-Pierre
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5656562/
https://ncbi.nlm.nih.gov/pubmed/28440343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tpj.2017.8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak